Related content

GSK2878175, a pan‐genotypic non‐nucleoside NS5B polymerase inhibitor, in healthy and treatment‐naïve chronic hepatitis C subjects

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 25, Iss. 1, 2018-01 ,pp. : 19-27

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genotypic shift of the hepatitis A virus and its clinical impact on acute hepatitis A in Korea: a nationwide multicenter study

By Kim Ji Hoon   Yeon Jong Eun   Baik Soon Koo   Kim Young Seok   Kim Hong Soo   Park Sang Hoon   Lee Myung-Seok   Sohn Joo Hyun   Lee Jin-Woo   Choi Sung Kyu   Kwon So Young   Choi Jong Young   Kim Ju Hyun   Kang Soon Young   An Hyonggin   Seo Yeon Seok   Yim Hyung Joon   Song Jin-Won   Um Soon Ho   Byun Kwan Soo  

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 11, 2013-11 ,pp. : 811-818

Informa Healthcare

Access to resources Recommend Favorite

Seroprevalence, genotypic distribution and potential risk factors of hepatitis B and C virus infections among adults in Siem Reap, Cambodia

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 4, 2015-04 ,pp. : 480-487

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of hepatitis C: the use of the new pangenotypic direct‐acting antivirals in “special populations”

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. S1, 2018-02 ,pp. : 28-33

John Wiley & Sons Inc

Access to resources Recommend Favorite

Optimised Conditions for the Production of Hepatitis B Virus from Cell Culture

By  

Intervirology, Vol. 44, Iss. 6, 2002-01 ,pp. : 370-378

Karger

Access to resources Recommend Favorite